Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor reverses diabetes in NOD mice

被引：0
|
作者：
Suarez-Pinzon, Wilma L.
Cembrowski, George S.
Rabinovitch, Alex
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A444 / A444
页数：1
相关论文
共 50 条
  • [21] Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Aletti, Rachael
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2012, 20 (01) : 45 - 51
  • [22] Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Neumiller, Joshua J.
    Campbell, R. Keith
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (18) : 1515 - 1525
  • [23] Alogliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Jarvis, Courtney I.
    Cabrera, Adriana
    Charron, Derek
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1532 - 1539
  • [24] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Carolyn F. Deacon
    Jens J. Holst
    Advances in Therapy, 2009, 26 : 488 - 499
  • [25] Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Johnson, Kathryn M. S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (04) : 455 - 463
  • [26] The Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Mouse Colon Tumorigenesis in Type 2 Diabetes Mice
    Yorifuji, Naoki
    Inoue, Takuya
    Fujiwara, Kaori
    Iguchi, Munetaka
    Kojima, Yuichi
    Okada, Toshihiko
    Kakimoto, Kazuki
    Nouda, Sadaharu
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S577 - S577
  • [27] Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes
    Goldstein, Barry J.
    Feinglos, Mark N.
    Lunceford, Jared K.
    Johnson, Jeremy
    Williams-Herman, Debora E.
    DIABETES CARE, 2007, 30 (08) : 1979 - 1987
  • [28] Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy
    Yamagishi, Sho-ichi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (07)
  • [29] Management of Patients Using Combination Therapy With Pioglitazone and a Dipeptidyl Peptidase-4 Inhibitor: An Analysis of Initial Versus Sequential Combination Therapy
    Bron, Morgan
    Ayyagari, Rajeev
    Sharma, Hari
    Chen, Kristina
    Bozas, Ana
    Wu, Eric
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 47 - 55
  • [30] Intensive monitoring for post-transplant diabetes mellitus and treatment with dipeptidyl peptidase-4 inhibitor therapy
    Thiruvengadam, Srivathsan
    Hutchison, Brian
    Lim, Wai
    Bennett, Kirsten
    Daniels, Gloria
    Cusack, Narelle
    Jacques, Angela
    Cawley, Brett
    Thiruvengadam, Shreyas
    Chakera, Aron
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 1857 - 1863
12345